These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14441424)

  • 1. The production of cardiac hypertrophy by thyroxine in the rat.
    SANDLER G; WILSON GM
    Q J Exp Physiol Cogn Med Sci; 1959 Jul; 44():282-9. PubMed ID: 14441424
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of thyroxin, testosterone and somatotropic hormone on experimental hypertrophy of the rat heart].
    POZZI LL; CAGNONI M; FANTINI F
    Rass Neurol Veg; 1959 Apr; 14():135-43. PubMed ID: 14434612
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac performance in heart-lung preparations of rats with experimental cardiac hypertrophy.
    Korecky B; Beznak M; Korecka M
    Can J Physiol Pharmacol; 1966 Jan; 44(1):21-7. PubMed ID: 4223062
    [No Abstract]   [Full Text] [Related]  

  • 4. Regression of thyroid hormone induced cardiac hypertrophy: effect on cardiac beta receptors and adenyl cyclase activity.
    Atkins FL; Carney R; Love S
    Life Sci; 1983 Aug; 33(7):679-85. PubMed ID: 6308378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroxine-induced cardiomegaly in rats of different age.
    Wachtlová M; Ostádal B; Mares V
    Physiol Bohemoslov; 1985; 34(5):385-94. PubMed ID: 2933754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faster protein and ribosome synthesis in thyroxine-induced hypertrophy of rat heart.
    Siehl D; Chua BH; Lautensack-Belser N; Morgan HE
    Am J Physiol; 1985 Mar; 248(3 Pt 1):C309-19. PubMed ID: 3156508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial Rac1 exhibits partial involvement in thyroxin-induced cardiomyocyte hypertrophy and its inhibition is not sufficient to improve cardiac dysfunction or contractile abnormalities in mouse papillary muscles.
    Elnakish MT; Moldovan L; Khan M; Hassanain HH; Janssen PM
    J Cardiovasc Pharmacol; 2013 Jun; 61(6):536-44. PubMed ID: 23429587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compensated coronary microvascular growth in senescent rats with thyroxine-induced cardiac hypertrophy.
    Tomanek RJ; Connell PM; Butters CA; Torry RJ
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H419-25. PubMed ID: 7840292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein synthesis and degradation during regression of thyroxine-induced cardiac hypertrophy.
    Coleman PS; Parmacek MS; Lesch M; Samarel AM
    J Mol Cell Cardiol; 1989 Sep; 21(9):911-25. PubMed ID: 2530358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulation of RNA synthesis in the rat heart in L-thyroxine toxicosis and hypothyroidism; the role of RNA-polymerases and the template activity of chromatin].
    Karsanov NV; Smolenskaia LI; Dzhagarov DE; Varazanashvili NA
    Ukr Biokhim Zh (1978); 1986; 58(6):8-15. PubMed ID: 2432716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the factors influencing cardiac growth. III. Digitoxin treatment and thyroxine-induced cardiac hypertrophy in the rat.
    Nosztray K; Szabó J; Takács IE; Szegi J
    Acta Biol Hung; 1986; 37(3-4):209-18. PubMed ID: 2450432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cissampelos pareira Linn. ameliorates thyroxin-induced cardiac hypertrophy in rats.
    Singh BK; Pillai KK; Kohli K; Haque SE
    J Ethnopharmacol; 2016 Feb; 178():281-8. PubMed ID: 26647106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The cytology of the intramural ganglia of the heart in experimental thyroxin poisoning].
    DE BIASE G; FAZZINI PF; FICI F
    Arch De Vecchi Anat Patol; 1961 Apr; 35():137-72. PubMed ID: 13884134
    [No Abstract]   [Full Text] [Related]  

  • 14. Thyroxine-induced cardiomegaly: assessment of nucleic acid, protein content and myosin ATPase of rat heart.
    Szabó J; Nosztray K; Takács I; Szegi J
    Acta Physiol Acad Sci Hung; 1979; 54(1):69-79. PubMed ID: 94743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective actions of human tissue kallikrein gene in transgenic rat hearts.
    Silva JA; Silva MR; Nascimento JW; Bader M; Pesquero JB
    Int Immunopharmacol; 2008 Feb; 8(2):267-70. PubMed ID: 18182238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AdipoRon prevents l-thyroxine or isoproterenol-induced cardiac hypertrophy through regulating the AMPK-related pathway.
    Hu X; Ou-Yang Q; Wang L; Li T; Xie X; Liu J
    Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):20-30. PubMed ID: 30566571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary-artery enlargement in experimental cardiac hypertrophy.
    Kerr A; Bommer WJ; Pilato S
    Am Heart J; 1968 Jan; 75(1):144. PubMed ID: 4229458
    [No Abstract]   [Full Text] [Related]  

  • 18. T4-induced cardiac hypertrophy disrupts cyclic GMP mediated responses to brain natriuretic peptide in rabbit myocardium.
    Katz E; Zhang Q; Weiss HR; Scholz PM
    Peptides; 2006 Sep; 27(9):2276-83. PubMed ID: 16762459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of angiotensin II type 1 receptor diminishes cardiac hypertrophy, but does not abolish thyroxin-induced preconditioning.
    Pantos C; Paizis I; Mourouzis I; Moraitis P; Tzeis S; Karamanoli E; Mourouzis C; Karageorgiou H; Cokkinos DV
    Horm Metab Res; 2005 Aug; 37(8):500-4. PubMed ID: 16138263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some functional changes in experimentally induced cardiac overload.
    Petkov O
    Acta Physiol Pharmacol Bulg; 1983; 9(3):42-50. PubMed ID: 6230880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.